Entering text into the input field will update the search result below

Navidea Biopharmaceuticals' (NAVB) CEO Michael Goldberg on Q4 2017 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Navidea Biopharmaceuticals (OTC:NAVB) Q4 2017 Earnings Conference Call March 8, 2018 4:30 PM ET


Jed Latkin - Chief Financial Officer and Chief Operating Officer

Michael Goldberg - President and Chief Executive Officer



Please stand by. Good day and welcome to Navidea Analyst Call. Today's call is being recorded. At this time, I'd like to turn the call over to Jed Latkin. Please go ahead.

Jed Latkin

Thank you. And welcome everyone to this morning's - this evening's earnings conference call. This call will cover Navidea's financial and operating results for the fourth quarter and full year ended December 31, 2017, along with the discussion of our goals and milestones for 2018. Following our prepared remarks, we will open up the conference call to a question-and-answer session. Our call today will be led by our Chief Executive Officer, Dr. Michael Goldberg.

But before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call may be considered forward-looking statements within the meaning of Section 27A of Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. That concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. Words such as expects, anticipates, intends, plans, aims, targets, believes, seeks, estimates, optimizing, potential, goals, suggests and similar expressions identify forward-looking statements.

These forward-looking statements relate to the effectiveness of the company's bodily-fluid-based diagnostic tests as well as the company's ability to develop and successfully commercialize such test platforms for early detection of cancer and other indications. The company's actual results may differ materially from those indicated in these forward-looking statements due to numerous risks and uncertainties.

For instance, if we

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About NAVB

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on NAVB

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.